Shandong Boyuan Pharmaceutical &Chemical Co.,Ltd(301617)
Search documents
化学制品板块9月1日涨0.37%,*ST金泰领涨,主力资金净流出3.61亿元





Zheng Xing Xing Ye Ri Bao· 2025-09-01 08:40
Market Performance - The chemical products sector increased by 0.37% on September 1, with *ST Jintai leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] Top Gainers in Chemical Sector - *ST Quantai (300225) closed at 5.79, up 12.21% with a trading volume of 366,800 shares and a turnover of 204 million yuan [1] - Kangda New Materials (002669) closed at 15.46, up 10.04% with a trading volume of 305,700 shares [1] - Jianye Co. (603948) closed at 32.09, up 10.01% with a trading volume of 25,800 shares [1] - Dinglong Technology (603004) closed at 24.42, up 10.00% with a trading volume of 78,100 shares [1] - Zanyu Technology (002637) closed at 12.02, up 9.97% with a trading volume of 154,400 shares [1] Top Losers in Chemical Sector - Akole (603722) closed at 51.95, down 7.99% with a trading volume of 75,000 shares and a turnover of 392 million yuan [2] - Jiabiyou (688089) closed at 27.36, down 5.07% with a trading volume of 122,100 shares [2] - Andyshi (66ZOO9) closed at 10.07, down 4.82% with a trading volume of 271,400 shares [2] Capital Flow Analysis - The chemical products sector experienced a net outflow of 361 million yuan from institutional investors, while retail investors saw a net inflow of 243 million yuan [2][3] - Kangda New Materials (002669) had a net inflow of 1.21 billion yuan from institutional investors, but a net outflow of 55.12 million yuan from retail investors [3] - Zanyu Technology (002637) had a net inflow of 61.87 million yuan from institutional investors, with a net outflow of 32.00 million yuan from retail investors [3]
博苑股份(301617) - 2025年8月29日投资者关系活动记录表
2025-09-01 00:17
Group 1: Market Overview - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, with applications in X-ray contrast agents, disinfectants, and LCD/LED screens [2] - The downstream application structure of iodine includes three core areas: X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, accounting for approximately 63% of global consumption [2] - Major iodine production is concentrated in Chile, Japan, and the USA, which together account for 88% of global sales, with Chilean companies alone contributing 60% [2][3] Group 2: Product Portfolio - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydrogen iodide, and cuprous iodide, primarily used in pharmaceuticals, pesticides, and optoelectronic materials [4] - The organic iodide product trimethyl iodide is utilized as a protecting agent in pharmaceutical synthesis, particularly in the production of antibiotics [4] Group 3: Competitive Advantages - The company integrates resource recycling with core business, creating a circular economy model that ensures stable supply and low costs [5] - A strong R&D team with over 30 years of industry experience has led to the acquisition of 51 patents, enhancing the company’s technological capabilities [5] - The company maintains a leading market position in iodides and luminescent materials, with established long-term partnerships with renowned clients [5][6] Group 4: Quality and Compliance - A comprehensive quality control system spans procurement, production, and sales, ensuring high-quality products and stable supply [6] - The company adheres to compliance in operations, holding all necessary safety and environmental permits, which fosters customer trust and supports sustainable growth [6]
环球市场动态:特朗普解职库克使降息预期增加
citic securities· 2025-08-27 02:43
Market Overview - A-shares showed mixed performance with the Shanghai Composite Index down 0.39% at 3,868 points, while the Shenzhen Component rose 0.26%[18] - U.S. stocks experienced slight gains, with the Dow Jones up 0.3% to 45,418 points and the S&P 500 rising 0.4% to 6,465 points[11] - European markets were weak, with the Stoxx 600 index down 0.83% and the French CAC 40 dropping 1.7% due to political uncertainties[11] Interest Rate Expectations - The market anticipates a more dovish stance from the Federal Reserve following Trump's dismissal of Fed Governor Cook, increasing expectations for rate cuts[6] - The implied probability of a rate cut in September has risen to nearly 90%[31] - The Fed is expected to cut rates three times in 2025, each by 25 basis points[6] Commodity and Currency Movements - The U.S. dollar weakened, with the Dollar Index down 0.2% to 98.23, while gold prices rose, reflecting market uncertainty[28] - International oil prices fell after four consecutive days of gains, with WTI crude down 2.39% to $63.25 per barrel[27] Fixed Income Market - U.S. Treasury yields saw a decline, with the 2-year yield down 4.5 basis points to 3.68% and the 10-year yield down 1.4 basis points to 4.26%[31] - The yield curve steepened as short-term bonds rallied amid strong demand in the 2-year auction[31] Corporate Highlights - Bilibili reported Q2 2025 revenue of 7.383 billion yuan, a year-on-year increase of 19.8%, exceeding Bloomberg consensus estimates[9] - Workday's Q2 2026 revenue reached $2.348 billion, up 14% year-on-year, also surpassing expectations[9]
博苑股份今日大宗交易折价成交9万股,成交额459万元
Xin Lang Cai Jing· 2025-08-26 08:55
8月26日,博苑股份大宗交易成交9万股,成交额459万元,占当日总成交额的0.92%,成交价51元,较市场收盘价53.99元折 价5.54%。 | 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交星 | 成交金额 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | (万元) | | | | 2025-08-26 | 301617 | 博苑股份 | 51.00 | 9.00 | 459.00 | 长江证券股份有限 | 长江证券股份有限 | | | | | | | | 公司北京百万庄大 | 公司武汉珞瑜路证 | | | | | | | | 街证券营业部 | 券营业部 | ...
博苑股份换手率37.96%,机构龙虎榜上出现分歧
Zheng Quan Shi Bao Wang· 2025-08-25 09:17
Summary of Key Points Core Viewpoint - 博苑股份 experienced a significant increase of 9.36% in its stock price, with a trading volume of 6.68 billion yuan and a turnover rate of 37.96% on the day of reporting [2] Trading Activity - The stock was highlighted on the exchange due to its high turnover rate, with institutional investors net buying 38.94 million yuan and the Shenzhen Stock Connect net buying 17.83 million yuan [2] - The top five trading departments accounted for a total transaction volume of 281 million yuan, with a net buying amount of 69.14 million yuan [2] Institutional Participation - Five institutional special seats were involved in the trading, with a total buying amount of 68.47 million yuan and selling amount of 29.53 million yuan, resulting in a net buying of 38.94 million yuan [2] - The Shenzhen Stock Connect was the largest buying and selling department, with a buying amount of 75.06 million yuan and a selling amount of 57.23 million yuan, leading to a net buying of 17.83 million yuan [2] Fund Flow - The stock saw a net inflow of 6.74 million yuan from main funds, with large orders experiencing a net outflow of 2.49 million yuan and smaller orders seeing a net inflow of 9.23 million yuan [2] - Over the past five days, the main funds have seen a net inflow of 75.78 million yuan [2]
博苑股份:公司产品无机碘化物主要产品包括碘化钾、碘酸钾等
Zheng Quan Ri Bao Zhi Sheng· 2025-08-25 08:08
Core Viewpoint - The announcement from Boyuan Co., Ltd. highlights the company's focus on inorganic and organic iodides, emphasizing their applications in various industries such as pharmaceuticals, pesticides, animal feed, and optoelectronic materials [1] Group 1: Inorganic Iodides - The main products of the company in the inorganic iodide category include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide [1] - These inorganic iodides are primarily utilized in the pharmaceutical, pesticide, animal feed, and optoelectronic materials sectors [1] Group 2: Organic Iodides - The company's organic iodide product, trimethyl iodide silane, serves as a functional group protecting agent in organic synthesis [1] - This product is mainly applied in the pharmaceutical industry, particularly in the production of antibiotics such as cephalosporins and macrolides [1]
博苑股份:公司核心竞争优势包括循环发展与综合服务优势等
Zheng Quan Ri Bao Zhi Sheng· 2025-08-25 08:08
(编辑 袁冠琳) 证券日报网讯 博苑股份8月25日发布公告,在公司回答调研者提问时表示,公司的核心竞争优势包括五 个方面:循环发展与综合服务优势、技术研发优势、产品质量与客户资源、行业地位优势、合规经营优 势。 ...
博苑股份:碘及碘衍生物广泛应用于各类产品配方中
Zheng Quan Ri Bao Zhi Sheng· 2025-08-25 08:08
Core Viewpoint - The announcement by Boyuan Co. highlights the significance of iodine and its derivatives as essential raw materials across various sectors, including healthcare, agriculture, and industry, with a focus on their applications in key products [1] Industry Overview - Iodine is widely used in various formulations as a key component or catalyst, with applications in X-ray contrast agents, disinfectants, pharmaceutical intermediates, LCD and LED screen polarizers, chemicals, organic compounds, and pigments [1] - Iodine is added to table salt in the form of potassium iodate or potassium iodide to prevent iodine deficiency [1] Market Structure - According to SQM's 2024 report, the downstream application structure of iodine is dominated by three core sectors: X-ray contrast agents, pharmaceutical manufacturing, and liquid crystal panel manufacturing, which together account for approximately 63% of global consumption [1] - The global iodine industry exhibits a distinct regional distribution, with major production concentrated in Chile, Japan, and the United States, which collectively account for 88% of global sales [1] - Five companies in Chile account for about 60% of global iodine sales, with SQM alone representing approximately 37% of this total; eight Japanese producers contribute around 23%, while U.S. producers account for nearly 5% [1] - Additional production exists in Russia, Turkmenistan, Azerbaijan, Indonesia, and China, albeit in smaller quantities [1]
博苑股份8月22日获融资买入8520.40万元,融资余额1.52亿元
Xin Lang Cai Jing· 2025-08-25 01:46
Group 1 - On August 22, Boyuan Co., Ltd. saw a stock price increase of 8.61% with a trading volume of 598 million yuan [1] - The financing buy amount for Boyuan Co., Ltd. on the same day was 85.204 million yuan, with a net financing purchase of 36.4176 million yuan [1][2] - As of August 22, the total financing and securities lending balance for Boyuan Co., Ltd. was 152 million yuan, accounting for 9.36% of its circulating market value [2] Group 2 - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with its listing date set for December 11, 2024 [2] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2] - The revenue composition of Boyuan Co., Ltd. includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] Group 3 - As of August 20, the number of shareholders for Boyuan Co., Ltd. was 13,200, a decrease of 0.14% from the previous period [3] - The average circulating shares per person increased by 0.14% to 2,524 shares [3] - For the first half of 2025, Boyuan Co., Ltd. achieved an operating income of 747 million yuan, a year-on-year increase of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.0429 million yuan [3] Group 4 - Boyuan Co., Ltd. has cumulatively distributed 88.408 million yuan in dividends since its A-share listing [4]
调研速递|博苑股份接受民生证券等1家机构调研 精彩要点披露
Xin Lang Cai Jing· 2025-08-25 01:46
Group 1 - The core viewpoint of the news is that Boyuan Co., Ltd. is actively engaging with investors to discuss its iodine and iodine derivative products, which are essential in various fields such as medicine, agriculture, and industry [1] - Iodine and its derivatives are widely used in X-ray contrast agents, disinfectants, and LCD/LED screen polarizers, with the pharmaceutical manufacturing, X-ray contrast agents, and liquid crystal panel manufacturing being the three main downstream applications, accounting for approximately 63% of global consumption [1] - The global iodine industry is predominantly concentrated in Chile, Japan, and the United States, which together account for nearly 95% of global sales, with some production also occurring in Russia and China [1] Group 2 - Boyuan Co., Ltd. possesses several core competitive advantages, including a circular economy model that integrates resource recycling with its main business, enhancing customer loyalty through comprehensive service [2] - The company has a stable and professional R&D team with over 30 years of industry experience, holding 51 patents as of June 30, 2025, and has established a leading technical strength in the industry [2] - Boyuan Co., Ltd. has built a comprehensive quality control system, ensuring stable product quality and maintaining long-term cooperation with many well-known enterprises, thereby establishing a good reputation [2] - The company is a market leader in iodine compounds and luminescent materials, gradually increasing its market share in hexamethyldisilazane, and has participated in the formulation of multiple industry standards, demonstrating its industry influence [2] - Boyuan Co., Ltd. has obtained various qualifications and established a safety production management system, continuously recognized as an advanced environmental protection unit, which has earned customer trust [2]